c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia

Genomic DNA from 60 cases of acute myeloid leukaemia (AML) was screened for mutations in the c‐kit gene. DNA from all 21 exons was subjected to polymerase chain reaction (PCR) amplification and analysis by conformation sensitive gel electrophoresis (CSGE); exons showing altered CSGE patterns were then sequenced. Mutations were identified only in those patients with inv(16) (3/7 cases) or t(8;21) (1/2 cases) and comprised three in‐frame deletion plus insertion mutations (exon 8) and one point mutation (exon 10, GTA → ATA, Val530Ile). Exons 8 and 10 were then analysed in 31 further cases of inv(16) (n = 14) and t(8;21) (n = 17), revealing four additional exon 8 in‐frame deletion plus insertion mutations, all of which were in cases of inv(16). All exon 8 in‐frame deletion plus insertion mutations (n = 7) involved the loss or repacement of the codon for Asp419 which is highly conserved cross species and is located in the receptor's extracellular domain. The high frequency of the c‐kit proto‐oncogene exon 8 deletion plus insertion mutations in AML suggests an essential role for this region of the receptor's extracellular domain. The association with inv(16) invites speculation as to the link between these two changes in the pathogenesis of AML.

[1]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[2]  G. Dolan,et al.  Precise Carrier Diagnosis in Families with Haemophilia A: Use of Conformation Sensitive Gel Electrophoresis for Mutation Screening and Polymorphism Analysis , 1998, Thrombosis and Haemostasis.

[3]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[4]  V. Broudy,et al.  Stem cell factor and hematopoiesis. , 1997, Blood.

[5]  Y. J. Kim,et al.  Molecular cloning of cDNA encoding the c-kit receptor of Shiba goats and a novel alanine insertion specific to goats and sheep in the kinase insert region. , 1997, Biochimica et biophysica acta.

[6]  O. Katoh,et al.  c-kit Point mutation in patients with myeloproliferative disorders. , 1997, Leukemia & lymphoma.

[7]  F. Galibert,et al.  Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. , 1997, Genomics.

[8]  L. Larizza,et al.  A novel potentially diagnostic polymorphism (4894 A/C) in exon 10 of the human c-kit proto-oncogene. , 1996, Molecular and cellular probes.

[9]  H. Koeffler,et al.  Analysis of c-kit gene integrity in aplastic anemia. , 1996, Blood cells, molecules & diseases.

[10]  Laura H. Tang,et al.  Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm , 1996, Nature Genetics.

[11]  Y. Matsuzawa,et al.  Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. , 1996, Blood.

[12]  Y. Suzuki,et al.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Y. Yarden,et al.  Structural Aspects of Receptor Dimerization , 1995 .

[14]  Y. Matsuzawa,et al.  Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. , 1995, International archives of allergy and immunology.

[15]  Y. Yarden,et al.  Structural aspects of receptor dimerization. c-kit as an example. , 1995, Annals of the New York Academy of Sciences.

[16]  Y. Matsuzawa,et al.  Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation , 1994 .

[17]  Kubota Takayuki,et al.  Sequence of a bovine c-kit proto-oncogene cDNA. , 1994 .

[18]  T. Kubota,et al.  Sequence of a bovine c-kit proto-oncogene cDNA. , 1994, Gene.

[19]  L. Rohrschneider,et al.  The effect of activating mutations on dimerization, tyrosine phosphorylation and internalization of the macrophage colony stimulating factor receptor. , 1994, Molecular biology of the cell.

[20]  C. Decastro,et al.  Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots. , 1993, Leukemia.

[21]  L. Ashman,et al.  Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. , 1993, The Journal of clinical investigation.

[22]  D. Birnbaum,et al.  Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. , 1993, Blood.

[23]  Sasaki Erika,et al.  Cloning and expression of the chicken c-kit proto-oncogene. , 1993 .

[24]  P. Martiat,et al.  Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapse , 1993, British journal of haematology.

[25]  H. Kitayama,et al.  Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. , 1993, Leukemia & lymphoma.

[26]  M. Naito,et al.  Cloning and expression of the chicken c-kit proto-oncogene. , 1993, Gene.

[27]  M. Roussel,et al.  Random mutagenesis of CSF‐1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. , 1992, The EMBO journal.

[28]  R. Spritz,et al.  Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. , 1992, American journal of human genetics.

[29]  H. Kitayama,et al.  Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. , 1991, Blood.

[30]  E. Morii,et al.  Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene. , 1991, Blood.

[31]  K. Davies,et al.  Molecular biology of the W and steel loci. , 1991 .

[32]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[33]  M. Minden,et al.  The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. , 1989, Leukemia.

[34]  F. Ruddle,et al.  Primary structure of c‐kit: relationship with the CSF‐1/PDGF receptor kinase family–oncogenic activation of v‐kit involves deletion of extracellular domain and C terminus. , 1988, The EMBO journal.

[35]  A. Ullrich,et al.  Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.

[36]  A. Ullrich,et al.  Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.

[37]  John E. Murphy,et al.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family , 1986, Nature.

[38]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.